Low levels of fibrin-stabilizing factor (factor XIII) in human Plasmodium falciparum malaria: Correlation with clinical severity

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 1, 1999, Pages 99-104

  Holst, Friedrich Georg Ernst ^a   Hemmer, Christoph Josef ^b   Foth, Christian ^b   Seitz, Rainer ^c   Egbring, Rudolf ^d   Dietrich, Manfred ^b  

^a Diakonie Krankenhaus Wehrda   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BLOOD CLOTTING FACTOR 13; DOXYCYCLINE; LEUKOCYTE ELASTASE; MEFLOQUINE; PROCOAGULANT; QUININE; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; MALARIA; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTEIN DEGRADATION; THROMBOEMBOLISM; VASCULAR ENDOTHELIUM;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032921230     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.99     Document Type: Article

References (41)

1. Horstmann RD, Dietrich M, 1985. Haemostatic alterations in malaria correlate to parasitaemia. Blut 51: 329-335.
2. Hemmer CJ, Kern P, Holst FGE, Radtke KP, Egbring R, Bierhaus A, Nawroth PP, Dietrich M, 1991. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombinantithrombin III, and protein C levels. Am J Med 91: 37-43.
3. Pukrittayakamee S, White NJ, Clemens R, Chittamas S, Karges HE, Desakorn V, Looareesuwan S, Bunnag D, 1989. Activation of the coagulation system in falciparum malaria. Trans R Soc Trop Med Hyg 83: 762-766.
4. Oo MM, Aikawa M, Than T, Aye TM, Myint PT, Igarashi I, Schoene W, 1987. Human cerebral malaria: a pathological study. J Neuropathol Exp Neurol 46: 223-231.
5. Kern P, Hemmer ChJ, van Damme J, Gruss HJ, Dietrich M 1989. Elevated tumor necrosis factor a and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 87: 139-143.
6. van der Poll T, van Deventer SJ, Hack CE, Wolbink GJ, Aarden LA, Buller HR, ten Cate JW, 1992. Effects of leukocytes after injection of tumor necrosis factor into healthy humans. Blood 79: 693-698.
7. Suttorp N, Nolte A, Wilke A, Drenckhahn D, 1993. Human neutrophil elastase increases permeability of cultured pulmonary endothelial cell monolayers. Int J Microcirc Clin Exp 13: 187-203.
8. Hemmer ChJ, Bierhaus A, von Riedesel J, Gabat S, Liliensiek B, Pitronik P, Lin J, Grauer A, Amiral J, Ziegler R, Schieffer S, Kern P, Seitz R, Egbring R, Dietrich M, Nawroth PP, 1994. Elevated thrombomodulin levels as a result of endothelial involvement in Plasmodium falciparum malaria. Thromb Haemost 72: 457-464.
9. Brooks MH, Kiel FW, Sheehy TW, Barry KG, 1968. Acute pulmonary edema in falciparum malaria: a clinico-pathological correlation. N Engl J Med 279: 732-737.
10. Bhamarapravati N, Boonpucknavig S, Boonpucknavig V, Yaemboonruang C, 1973. Glomerular changes in acute Plasmodium falciparuin infection: an immunopathologic study. Arch Pathol 96: 289-293.
11. Sitprija V, Vongsthongsri M, Opshyachinda V, Arthachinta S, 1977. Renal failure in malaria: a pathophysiologic study. Nephron 18: 277-287.
12. Klingemann HG, Egbring R, Holst F, Gramse M, Havemann K, 1982. Degradation of human factor XIII subunits by human granulocytic proteinases. Thromb Res 28: 793-796.
13. Rasche H, 1975. Blutgerinnungsfaktor XIII und Fibrinstabilisierung. Klin Wochenschr 53: 1137-1145.
14. Board PG, Losowsky MS, Miloszewski KJ, 1993. Factor XIII, inherited and acquired deficiency. Blood Rev 7: 229-242.
15. Egbring R, Schmidt W, Fuchs G, Havemann K, 1977. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 49: 219-231.
16. Seitz R, Wolf M, Egbring R, Havemann K, 1989. The disturbance of hemostasis in septic shock: role of neutrophil HN-elastase and thrombin, effects of antithrombin III and plasma substitution. Eur J Haematol 43: 22-28.
17. Kuratsuji T, Oikawa T, Fukumoto T, Shimizu S, Iwasaki Y, Tomita Y, Meguro T, Yamada K, 1982. Factor XIII deficiency in antibiotic-associated pseudomembranous colitis and its treatment with factor XIII concentrate. Haemostasis 11: 229-234.
18. Suzuki R, Toda H, Takamura Y 1989: Dynamics of blood coagulation faktor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut 59: 162-164.
19. Henriksson P, Hedner U, Nilsson IM, 1977. Factor XIII (fibrin stabilizing factor) in Henoch-Schönlein's Purpura. Acta Paediatr Scan 66: 273-277.
20. Hirahara K, Shinbo K, Takahashi M, Matsuishi T, 1993. Suppressive effect of human blood coagulation factor XIII on the vascular permeability induced by antiguinea pig endothelial cell antiserum in guinea pigs. Thromb Res 71: 139-148.
21. Holst FGE, Hemmer ChJ, Kern P, Dietrich M, 1994. Inappropriate secretion of antidiuretic hormone and hyponatremia in severe falciparum malaria. Am J Trop Med Hyg 50: 602-607.
22. Hemmer CJ, Hort G, Chiwakata CB, Seitz R, Egbring R, Gaus W, Hogel J, Hassemer M, Nawroth PP, Kern P, Dietrich M, 1997. Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am J Trop Med Hyg 56: 397-403.
23. Egbring R, Schmidt W, Havemann K, 1973. Die vereinfachte radiologische Faktor-XIII-Bestimmung und ihre klinische Anwendung bei kongenitalem Faktor XIII-Mangel. Blut 27: 6-19.
24. Laurell CB, 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45-52.
25. Neumann S, Gunzer G, Hennrich N, Lang H, 1984. "PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor. J Clin Chem Biochem 22: 693-697.
26. Pelzer H, Braun K, Schwarz A, Tourte E, Becker U, 1986. New approaches for the detection of early activation products in thrombotic states. Behring Inst Mitt 79: 80-86.
27. Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ, 1944. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol 87: 100-105.
28. Kaczmarek E, Liu Y, Berse B, Chen CS, McDonagh J, 1995. Biosynthesis of plasma factor XIII: evidence for transcription and translation in hepatoma cells. Biochim Biophys Acta 1247: 127-134.
29. Griffin TD, Murphy GF, Sueki H, Telegan B, Johnson WC, Ditre CM, Yu RJ, van Scott EJ, 1996. Increased factor XIIIa transglutaminase expression in dermal dendrocytes after treatment with alpha-hydroxy acids: potential physiologic significance. J Am Acad Dermatol 34: 196-203.
30. Huang YQ, Friedman-Kien AE, Li JJ, Nickoloff BJ, 1993. Cultured Kaposi sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Arch Dermatol 129: 1291-1296.
31. Weinberg JB, Pippen AM, Greenberg CS, 1991. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34: 996-1005.
32. Hudson M, Wakefield AJ, Hutton RA, Sankey EA, Dhillon AP, More L, Sim R, Pounder RE, 1993. Factor XIIIA subunit and Crohn's disease. Gut 34: 75-79.
33. Rodeghiero F, Barbui T, Battista R, Chisesi T, Rigoni G, Dini E, 1980. Molecular subunits and transamidase activity of factor XIII during disseminated intravascular coagulation in acute leukemia. Thromb Haemost 43: 1-5.
34. Duswald KH, Jochum M, Schramm W, Fritz H, 1985. Released granulocytic HN-elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery 98: 982-989.
35. Murata A, Toda H, Uda K, Hayashida H, Kato T, Nakagawa H, Yokohama S, Morishita H, Yamakawa T, Hirose J, 1994. Protective effect of recombinant neutrophil elastase inhibitor (R-020) on sepsis-induced organ injury in rats. Inflammation 18: 337-347.
36. Tanaka H, Sugimoto H, Yoshioka T, Sugimoto T, 1991. Role of granulocytic elastase in tissue injury in patients with septic shock complicated by multiple organ failure. Ann Surg 213: 81-85.
37. Smedly LA, Tonnesen MG, Sandhaus RA, 1986. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil HN-elastase. J Clin Invest 77: 1233-1243.
38. Movat HZ, Wasi S, 1985. Severe microvascular injury induced by lysosomal releasates of human polymorphonuclear leukocytes: increase in vasopermeability, hemorrhage, and microthrombosis due to degradation of subendothelial and perivascular matrices. Am J Pathol 121: 404-417.
39. Westlin WF, Gimbrone MA Jr, 1993 Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol 142: 117-128.
40. Stief TW, 1991. Factor XIII of blood coagulation inhibits the oxidative phagocyte metabolism and suppresses the immune response in vivo. Thromb Res 63: 227-238.
41. Sylven C, Chen J, Bergstrom K, Bjorkman L, Wallin R, Saldeen T, 1992. Fibrin(ogen)-derived peptide B beta 30-43 is a sensitive marker of activated neutrophils during fibrinolytic treated acute myocardial infarction in man. Am Heart J 124: 841-845.